Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Immunological Methods|October 21, 2019
Whole blood preservation methods alter chemokine receptor detection in mass cytometry experimentsSunniva Todnem Sakkestad, Jørn Skavland, Kurt HanevikExpert Review of Molecular Diagnostics|February 20, 2016
Single-cell proteomics: potential implications for cancer diagnosticsSonia Gavasso, Stein-Erik Gullaksen, Jørn Skavland, et al.BMC Immunology|July 13, 2010
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cellsElisabeth Ersvaer, Knut Liseth, Jørn Skavland, et al.Nutrition and Cancer|June 25, 2010
Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemiaEmmet McCormack, Jørn Skavland, Maja Mujic, et al.Journal of Clinical Medicine|August 4, 2015
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future DirectionsCaroline Benedicte Nitter Engen, Line Wergeland, Jørn Skavland, et al.Cancer Immunology, Immunotherapy : CII|April 14, 2006
Effects of interferon gamma on native human acute myelogenous leukaemia cellsElisabeth Ersvaer, Jørn Skavland, Elling Ulvestad, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 19, 2010
Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammationElvira Semaeva, Olav Tenstad, Jørn Skavland, et al.Pharmacological Research|August 21, 2016
Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cellsAndré Sulen, Stein-Erik Gullaksen, Lucius Bader, et al.Case Reports in Hematology|October 23, 2018
Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell TransplantationHåkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, et al.British Journal of Haematology|December 14, 2011
Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological interventionHåkon Reikvam, Kimberley J Hatfield, Elisabeth Ersvaer, et al.Pageof 3